Total Calcified Plaque Volume Test

Total calcified plaque is the measurement of hardened calcium deposits within the walls of the coronary arteries, the vessels that supply oxygen-rich blood to the heart. These deposits form over years as part of atherosclerosis, the process where fatty, inflammatory, and fibrous materials build up inside the artery wall. Coronary computed tomography angiogram (CCTA) is a specialized heart CT scan that can detect and quantify these deposits without invasive procedures.

Calcium in the arteries develops when soft, fatty plaque undergoes a healing process that leaves behind mineralized areas. These calcified regions are generally more stable and less likely to rupture suddenly compared to soft, non-calcified plaque, which is more prone to causing acute coronary syndrome (ACS), a sudden blockage that can trigger a heart attack. Interestingly, research shows that very dense calcium (measured as over 1000 Hounsfield units on CT) is often linked to lower short-term risk of ACS. This means that the amount and density of calcified plaque can provide different kinds of information about risk.

The total amount of calcified plaque in your arteries is measured as a percentage of the total volume of the artery. A higher percentage means more calcified plaque relative to artery size. It is measured using coronary computed tomography angiogram (CCTA), a noninvasive imaging test that uses X-rays and contrast dye to create detailed 3D pictures of your heart’s arteries. In recent years, advanced computer algorithms and artificial intelligence have made CCTA faster, more accurate, and more reproducible.

CCTA can be very accurate for detecting narrowing in arteries with mild to moderate calcification. However, when calcium deposits are extensive, image clarity can suffer due to “blooming artifacts,” where the calcium looks larger and more obstructive than it actually is. This can make blockages seem worse than they are and reduce test specificity. Advanced imaging techniques and artificial intelligence can help reduce this limitation, but overestimation remains possible in heavily calcified arteries.

Medical therapy can also influence plaque composition. Statins, for example, often increase calcified plaque volume while reducing soft plaque. This does not necessarily mean the disease is worsening; rather, it reflects plaque becoming more stable and less likely to rupture. Over time, and especially with age or longstanding disease, the proportion of calcified plaque tends to rise, while the more dangerous non-calcified plaque may shrink.